Beckman Coulter Access Total T3 Assay Recalled for Biotin Interference
Beckman Coulter is recalling Access Total T3 Triiodothyronine assays because high levels of biotin can cause significant result bias.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves potential diagnostic inaccuracy due to biotin interference without reported injuries or illnesses, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
Beckman Coulter Inc. is recalling the Access Total T3 Triiodothyronine assay (REF 33830) for use with the Access Family of Immunoassay Systems. The recall involves 238,862 units distributed across the United States, US territories, and numerous international locations.
The recall was initiated because the firm characterized the potential interference effects of biotin on biotin-mediated Access assays. The Access Total T3 assay displayed significant interference, defined as a result bias greater than +/-10%, at biotin levels of 1,200 ng/mL. This interference can lead to inaccurate test results.
Healthcare facilities and laboratories should stop using the affected assays and contact Beckman Coulter for further instructions. The recall covers all lots of Catalog Number 33830.
The recalled product
- Product
- Beckman Coulter ACCESS Immunoassay Systems, Access Total T3 Triiodothyronine , REF 33830 (UDI: 15099590227210) for use with the Access Family of Immunoassay Systems including: Access 2, UniCel DxI 600, UniCel DxI 800, UniCel DxC 600i, UniCel DxC 660i, UniCel DxC 680i, UniCel…
- Manufacturer
- Beckman Coulter Inc.
- Affected units
- 238,862
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Catalog Number: 33830
- all lots.
Distribution
Part of a larger recall action
This product is one of 6 recalled by Beckman Coulter Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Beckman Coulter Inc.
See all →- ModerateBeckman Coulter DxC 500 AU Clinical Chemistry Analyzers Recalled for Software Error
FDA (Devices) · 2026-10-14
- ModerateBeckman Coulter Recalls DxC 500i Clinical Analyzer Modules Due to Software Error
FDA (Devices) · 2026-10-14
- HighBeckman Coulter DxC 500i Analyzer Modules Recalled for Software Defect
FDA (Devices) · 2026-08-26
- HighBeckman Coulter DxC 500 AU Analyzer Software Defect Recall
FDA (Devices) · 2026-08-26
- High
Same hazard · biotin interference
See all →- ModerateBeckman Coulter Access Thyroglobulin Immunoassay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Free T3 Immunoassay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- HighBeckman Coulter Access Thyroglobulin Antibody II Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- HighBeckman Coulter Access Free T4 Thyroxine Assay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Access GI Monitor Cancer Antigen 19-9 Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
Similar recalls
- ModerateBeckman Coulter Access Total T3 Immunoassay Recalled for Biotin Interference
FDA (Devices) · 2017-07-05
- HighBeckman Coulter Access System-Free T4 Assay Recalled for Biotin Interference
FDA (Devices) · 2017-07-05
- LowBeckman Coulter Access Total T3 Reagent Recalled for Negative Bias
FDA (Devices) · 2012-08-29
- ModerateBeckman Coulter Access Thyroglobulin Recalled for Biotin Interference
FDA (Devices) · 2017-07-05
- HighBeckman Coulter Recalls Access Free T3 Assay Kits Due to Result Shifts
FDA (Devices) · 2016-07-06
- ModerateBeckman Coulter Recalls Access Free T3 Reagent Kits Due to Filling Errors
FDA (Devices) · 2015-10-14